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ABSTRACT
On Thursday 9 May 1991, the world awoke to front-page news of a
breakthrough in biological research. FromWashington toWollongong,
newspapers, radio and TV were abuzz with the story of a transgenic
mouse in London called Randy. Why was this mouse so special?
The mouse in question was a chromosomal female (XX) made male
by the presence of a transgene containing the Y chromosome gene
Sry. This sex-reversal provided clear experimental proof that Sry was
the elusive mammalian sex-determining gene. Twenty-five years on,
we reflect on what this discovery meant for our understanding of how
males and females arise and what remains to be understood.
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Introduction
One of the most fundamental processes in biology is the
development of two sexes. Many great minds, from Aristotle to
Darwin, struggled with the question of how the two sexes arise.
However, by 1959 it was known that in eutherian mammals a gene
or genes on the Y chromosome initiates testis development in the
embryo and that the testes then produce all the hormones needed to
make a male. In the absence of the Y chromosome, the embryonic
gonads develop instead as ovaries. It was hoped that finding the
relevant gene(s), termed testis-determining factor (TDF in humans;
Tdy in mice), would eventually lead to a complete understanding
of the processes needed to generate a testis, providing a paradigm
for elucidating the morphogenesis of other organ systems. In
subsequent decades, TDF/Tdywas narrowed down to a small region
on the short arm of both the human and mouse Y by analysing XX
males carrying a small Y fragment. The overlap between this
fragment and the Y chromosome interval deleted in XY female
patients delimited TDF (Pritchard et al., 1987; Page et al., 1987),
enabling the search for the gene or genes defining that locus
to begin.
The discovery of SRY/Sry
The TDF gene was predicted to have five key properties. First, it
should be conserved amongst mammals. Second, it should be
located on the Y chromosome in all mammals and within the
smallest known sex-determining fragment of the Y chromosome in
mice and humans. Third, its product should most likely act cell-
autonomously and control the activity of other genes (Burgoyne
et al., 1988). Fourth, it should be expressed in the somatic
component of the developing testis at the time of sex determination
(Burgoyne et al., 1988). Finally, gene mutations should lead to
failure of testis development and to XY females, whether human
patients or mice.
Two research teams were strong contenders in the race to identify
TDF. In London, UK, Peter Goodfellow’s human molecular
genetics group teamed up with Robin Lovell-Badge’s mouse
developmental biology group to bring complementary expertise to
the problem. In Boston, David Page’s group led the race within the
USA. In December 1987, the Boston group published a strong
candidate for TDF, the gene encoding the zinc-finger protein ZFY
(Page et al., 1987). ZFYmapped to the smallest region of the human
Y chromosome found so far in XX males, was missing in XY
females and encoded a transcription factor that could act cell-
autonomously; but over the following two years, evidence
increasingly indicated that it was, in fact, the wrong gene. Its
marsupial homologue was found not to map to the Y chromosome
(Sinclair et al., 1988). ZFY was expressed ubiquitously in humans,
which did not fit well with the biology of TDF, while its mouse
homologues were neither expressed in somatic cells of the fetal
testis (Koopman et al., 1989) nor mutated in XY female mice known
to carry a heritable mutation mapping to the Y chromosome (Tdym1;
Lovell-Badge and Robertson, 1990; Gubbay et al., 1990). Crucially,
four variably masculinised XX patients with testicular tissue were
found to possess Y-derived markers but lack ZFY (Palmer et al.,
1989).
Fortunately, however, these same four patients held the key to
identifying a new candidate, as they had in common a mere 35 kb of
Y chromosome DNA. The Goodfellow group cut this region into
small fragments and tested each on Southern blots containing male
and female DNA from human, mice and cattle. Only one human
Y-fragment was identified that showed male-specific bands in
human and several other mammalian genomes (Sinclair et al., 1990),
as well as in XY and XX male mice [where the latter carried a small
region of the Y chromosome short arm termed Sxr(b) (Laval et al.,
1995)], but not XX or XYTdym1 female mice (Gubbay et al., 1990).
As unique sequences conserved between the Y chromosomes of
different mammalian species are very rare, these results implied that
this human Y chromosome fragment probably contained TDF/Tdy.
Sequencing revealed an open reading frame coding for a single
exon gene, cautiously named sex-determining region on the
Y chromosome (SRY in humans, Sry in mice: Sinclair et al., 1990;
Gubbay et al., 1990).
With this strong candidate in hand, it was relatively
straightforward to test its properties against the predictions made
for TDF. The first two were satisfied by Southern blotting, as
described above. In those experiments, additional bands were
observed that were not sex-specific – an early indication of the
existence of an Sry-related gene family later named Sox. Although
much of the SRY/Sry open reading frame was not well conserved,
both human and mouse sequences included a region encoding aReceived 9 March 2016; Accepted 21 March 2016
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79 amino acid domain with homology to a conserved DNA-binding
motif present in the nuclear high-mobility group proteins HMG1
and HMG2, and in the eukaryotic transcription factor UBF (Jantzen
et al., 1990). Shortly afterwards, a related ‘HMG domain’was found
in the transcription factors TCF1 and LEF1, further suggesting that
SRY was itself a transcription factor (van de Wetering et al., 1991;
Travis et al., 1991). RT-PCR experiments showed that Sry is
expressed in XY mouse fetal gonads at 11.5 days post coitum – the
time point immediately preceding the first morphological signs of
testis differentiation (Gubbay et al., 1990). Indeed, Sry is expressed
for only a brief period prior to sex determination in mouse gonads
and, like sex determination itself, does not depend on the presence
of germ cells (Koopman et al., 1990). Finally, de novo point
mutations affecting the SRY HMG domain were detected in DNA
from two human XY females, providing strong genetic evidence
that the function of SRY is required for testis development and male
sex determination (Berta et al., 1990). All the evidence pointed to
SRY/Sry being the right gene. But how could the putative role of
SRY/Sry be proved?
Making a male mouse
It was reasoned that the gene(s) representing Tdy should cause XX
sex reversal if introduced as a transgene via pronuclear injection into
mouse zygotes. A 14 kilobase (kb) genomic clone containing the
mouse Sry open reading frame and about 8 kb of 5′ and 5 kb of 3′
flanking DNAwas identified and mapped. This had been sequenced
and characterised sufficiently to be confident that there was no
additional ORF in the region, but there was no assurance that it
contained all the necessary sequences required for correct
quantitative, temporal and cell type-specific expression, or mRNA
stability. Without adding a tissue-specific promoter or insulator
sequences, the possibility that this small and naked genomic
fragment might function to drive male development seemed remote,
but it was worth a try.
Injected embryos were analysed at 14 days post coitum, some
36 h after the formation of testis cords, which, together with the
formation of a male pattern of gonad vasculature, make it possible to
visibly distinguish testes from ovaries. Chromosomal sex and the
presence or absence of the transgene were verified by PCR and/or
Southern blotting. Early experiments were disappointing. Then, in
one experiment, two out of four XX transgenic embryos had testes
indistinguishable from those of control XY embryos (Koopman
et al., 1991). Another two transgenic XX fetuses were female and
another four XX fetuses had low transgene copy numbers: six XX
females, in which mosaicism and/or unfavourable integration had
presumably precluded transgene function. The two sex-reversed
embryos were cause for relief and an ambrosial sense of triumph, but
there was little time to celebrate: there was much more work to do.
In subsequent experiments, mice were allowed to develop
through to birth after pronuclear injection. Five of these were
transgenic, including three XX. One of the latter looked to be an
entirely normal male externally (Fig. 1), was very willing and able
to mate with females, and sowas given the nickname Randy. He had
a normal male reproductive tract, but his testes were small and
devoid of spermatogenesis, entirely as predicted for an XX male:
two X chromosomes are incompatible with the proliferation of
spermatogonia after birth and other Y chromosome genes are
required to make sperm. Because the sex reversal in Randy was
complete, this was the final proof that Sry was not only necessary,
but also sufficient on its own to initiate male somatic development.
Thus, SRY/Sry was functionally and genetically equivalent to TDF/
Tdy. The paper was prepared with urgency and excitement (Fig. 2),
reviewed positively, accepted on 5 April and published within five
weeks as a feature article in Nature (Fig. 1).
By 1991, several transgenic mice had already hit the headlines.
These included big mice that overexpressed rat growth hormone
(Palmiter et al., 1982) and mice that developed specific tumours
(Brinster et al., 1984). However, many hundreds of others flew
below the radar and it was assumed that this one would not create
much of a stir in the media, especially because Randy looked like a
normal male mouse and there had already been media attention
around the discovery of SRY/Sry the previous year. We could not
have been more wrong!
Fig. 2. Making aNature cover.Never work with children or animals, the adage
goes. Certainly it can take more scientists than animals when it comes to
persuading mice to hang contentedly from a rod. Left-right: Nigel Vivian, Robin
Lovell-Badge, Peter Koopman and Neal Cramphorn. Image courtesy of
Jérôme Collignon.
Fig. 1. Complete sex reversal of an Sry transgenic mouse. The external
phenotype of XX transgenic mouse m33.13, also known as Randy (shown
here on the cover of the 9 May 1991 issue of Nature), was identical to that of a
wild-type XY male mouse. Image reproduced with permission from Nature
Publishing Group.
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The story made front-page news in the UK and spread from there
around the world (Fig. 3). Reporters, photographers, TV and radio
crews invaded the lab for weeks. The technical accomplishment, the
achievement of a significant milestone in genetics and possibly
some cute photos of mice, resonated with many. Some stories
trumped up a relevance to cancer, others questioned the ethics or
talked of a slippery slope, and yet others found the concept of ‘a sex-
change for Mickey’ mildly amusing.
The broader significance of the work undoubtedly lies in having
finally provided an answer to one of our most fundamental and
long-standing questions – why am I male or female? That a single
gene makes all the difference was a surprise to many. Scientifically,
the discovery of SRY/Sry helped to open the field of sex
determination. It provided an entry point into the genetics and
embryology underlying testis development, explained cases of sex
reversal, and provided an important new diagnostic. It also spurred
research into ovary development – the other half of the story of
gonadal sex determination.
Progress and current challenges
Proving the testis-determining role of SRY/Srywas expected to open
the gate to discovering the next gene in the pathway, and the one
after, such that a comprehensive picture of how sex determination
works at the molecular genetic level would be ‘quickly’ gained.
Things did not work out quite that way. SRY/Sry proved to be
extremely difficult to work with in almost every way imaginable.
The gene is small, intronless and, being from the Y chromosome,
embedded in a poorly conserved and highly repetitive DNA
sequence (Gubbay et al., 1992). It is expressed in a small number of
cells in an inaccessible fetal tissue for (in mice) only a brief period
(Albrecht and Eicher, 2001; Sekido et al., 2004; Wilhelm et al.,
2005). No specific antibody for SRY was produced for over a
decade (Bradford et al., 2007). Even initial efforts to define
its mRNA transcript literally had us going around in circles
(Capel et al., 1993). Immortal cell lines expressing SRY/Sry bore
questionable resemblance to fetal gonadal cells and primary
gonadal cells placed into culture quickly lost SRY/Sry expression
(Capel et al., 1996; Beverdam et al., 2003). The SRY binding site is
small and degenerate (Harley et al., 1992), hence putative target
sites are present throughout the genome. In short, standard
techniques for discovering upstream or downstream genes were
essentially unworkable for SRY/Sry (Larney et al., 2015).
Despite this, we now have a basic understanding of the SRY
protein’s cellular and molecular functions. SRY binds specifically
to DNA in one or more enhancers of the target gene Sox9, in order to
upregulate Sox9 transcription (Sekido and Lovell-Badge, 2008).
This occurs in just one cell lineage – the bipotential supporting cell
precursors that give rise to granulosa cells in the ovary or Sertoli
cells in the testis. SOX9, in turn, activates the expression of other
genes required for Sertoli cell differentiation and function, including
factors that instruct the other cell lineages within or adjacent to the
gonad to follow a male differentiation pathway (reviewed by
Svingen and Koopman, 2013). Importantly, SOX9 also promotes its
own expression, so that continued Sry expression is not required to
sustain testis differentiation or maintain testis phenotype. At the
same time, SOX9 and/or its direct or indirect targets repress genes
associated with ovarian development. In summary, Sry acts as a
trigger and Sox9 an effector in driving testis development (reviewed
by Canning and Lovell-Badge, 2002; Kashimada and Koopman,
2010). Not surprisingly, transgenic expression of Sox9 during XX
mouse fetal gonad development is as effective as Sry in inducing
testis development and maleness (Vidal et al., 2001).
As with all transcription factors, a threshold level of SRY/Sry
expression is required to activate Sox9. It is also clear that SRY/Sry
must act within a specified time window, otherwise it ‘misses the
boat’; transgenic mice in which Sry is expressed later than normal
via an inducible promoter do not switch on Sox9 and do not make
testes (Hiramatsu et al., 2009). Because the timing and levels of
SRY expression are integral to its sex-determining function,
considerable effort has focused on understanding the regulation of
SRY/Sry transcription. In mice, Sry expression is thought to be
activated by some combination of the core transcription factors
steroidogenic factor 1 (SF1), Wilms tumor 1 (WT1) and GATA
binding protein 4 (GATA4), although whether and how these factors
act specifically on Sry regulatory sequences are matters that remain
to be fully explained experimentally (reviewed by Larney et al.,
2014). A signal transduction pathway involving GADD45γ,
MAP3K4 and p38 MAPK (MAPK14) is also crucial (Warr et al.,
2012), although the extracellular ligands and their source have yet to
be identified. SRY/Sry is a rapidly evolving gene, so the specific
details may not be the same in all mammals.
Somewhat surprisingly, gonadal phenotype has emerged as
relatively labile. The deletion of Foxl2 from adult granulosa cells
allows Sox9 to be expressed, which then triggers transdifferentiation
to Sertoli cells. This leads to gonadal sex reversal, with the ovaries
exhibiting a structure and cell types resembling that of the testis
(Uhlenhaut et al., 2009). Conversely, loss of Dmrt1 in the adult
testis leads to upregulation of Foxl2 and repression of Sox9, and a
transformation from testicular to ovarian cell types (Minkina et al.,
2014). All of this suggests that there is no crucial role for chromatin
modifiers to lock down the system. Could this flexibility and the
Fig. 3. Media frenzy. Newspaper clippings reflecting the varied popular
interpretations of the significance of creating a sex-reversed mouse.
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need for continuous repression of the opposite pathway reflect an
evolutionary hangover from early vertebrate ancestors that could
change sex, as seen in some species of fish (Kobayashi et al., 2013)?
The discovery of SRY/Sry also encouraged a search for essential
sex-determining genes in non-mammalian vertebrates, where it is
absent, and consideration of how sex chromosomes and sex-
determining genes arose during evolution. Mapping of Sox3, one of
the original group of Sox genes co-discovered with Sry, and its
human homologue SOX3, to the mouse and human X
chromosomes, first suggested the prevailing model that Sry
evolved from Sox3 (Stevanovic ́ et al., 1993). SOX3 does not
seem to have any role in sex determination, but has conserved
functions during gastrulation, in the development of the central
nervous system, and in a few other tissues. It seems most likely
therefore that Sox3 was originally autosomal, as it still is in
prototherian mammals, and that a regulatory mutation led to
expression of one copy in the early gonad, where its protein product
promoted transcription of Sox9, which does appear to play a role in
Sertoli cell differentiation in all vertebrates. This variant Sox3
became Sry, the chromosome it was on became the Y chromosome,
and the chromosome retaining a normal Sox3 became the X
chromosome. In support of this model, situations where SOX3 is
mis-expressed in the early gonad can lead to XXmale sex reversal in
mice and probably in humans, perhaps mimicking events in
evolution (Sutton et al., 2011).
Despite much progress from many labs, we still do not have a
comprehensive picture of the regulatory networks leading to the
differentiation, maturation and maintenance of either the testis or the
ovary in mammals. Most causes of XY and XX gonadal dysgenesis,
other than those involving SRY, remain unknown. As was the case
with the original identification of SRY/Sry, co-ordinated efforts
involving multiple species will continue to drive progress in filling
these gaps. For example, transcriptomic studies in mice can identify
candidate disorders of sex development (DSD) genes that can be
tested for mutations in the DNA of DSD patients. Conversely, DSD
patient screening can identify new candidate genes that can be
characterised and functionally studied in mice. In this way, and
through the application of increasingly sophisticated biochemical
and genetic approaches, the field will continue to advance.
Concluding remarks
These days, it is hard to imagine the stir created by a single
transgenic mouse experiment in 1991. Given the lack of current
tools such as whole genome sequencing, internet-based
bioinformatic tools and advanced gene-editing tools such as
CRISPR/Cas9, it remains something of a miracle that within the
space of a couple of years, a plausible TDF/Tdy candidate was
identified and its function so definitively validated by the creation of
Randy the mouse. While Randy did not leave any direct
descendants, other transgenic mice made with Sry have been part
of his legacy. For example, the Tdym1 mutation, where Sry is
deleted from the Y chromosome, can be complemented by an Sry
transgene on an autosome to give fertile XY males. The four types
of offspring these would have produced when mated with XX
females would make it possible to distinguish direct effects of X-
and Y-linked genes from the effects of gonadal hormones on
differences between the sexes (De Vries et al., 2002). This ‘four core
genotype’ model has now been used to explore the basis of many
sex-specific differences, from neuroanatomy to food preferences.
Moreover, it has led to a more general appreciation of how
commonly such differences occur and their clinical importance
(Arnold, 2014). Sry could itself have roles outside the gonad.
Indeed, it is expressed in the brain in mice and other mammals
(Loke et al., 2015). This could place male-specific traits under
selection, perhaps explaining aspects of rapid Sry evolution. Finally,
the discovery of Sry also, importantly, led to the identification of
other members of the Sox gene family, of which there are 20 in man
and mouse (Schepers et al., 2002). These Sox genes, unlike Sry, are
highly conserved in evolution and have proved essential for many
cell fate decisions during embryogenesis. They are also clinically
relevant for both congenital disease and cancer. Quite an impressive
legacy from a sterile, albeit frisky, XX male mouse.
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